December 2023
1. HOU Z, Guo Y, Shen X, Dong B, et al
   Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study.
   Radiother Oncol. 2023;189:109937.
   

   >> Share

   
   November 2023
2. MENG Z, Li P, Yang D, Huang H, et al
   The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline.
   Radiother Oncol. 2023 Nov 24:110027. doi: 10.1016/j.radonc.2023.110027.
   

   >> Share

   
   
3. SOMAY E, Topkan E, Selek U
   Comment on: The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer.
   Radiother Oncol. 2023 Nov 24:110025. doi: 10.1016/j.radonc.2023.110025.
   

   >> Share

   
   
4. BUURMAN DJM, Speksnijder CM, Granzier ME, Timmer VCML, et al
   Response to: Comment on: The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer.
   Radiother Oncol. 2023 Nov 24:110026. doi: 10.1016/j.radonc.2023.110026.
   

   >> Share

   
   
5. DELERUE C, Pasquier D, Bogart E, Mirabel X, et al
   Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center.
   Radiother Oncol. 2023;190:110029.
   

   >> Share

   
   
6. HUANG CL, Wang GY, Lou JH, Chen L, et al
   Oral chemotherapy versus observation alone in nasopharyngeal carcinoma patients with persistently detected circulating cell-free Epstein-Barr virus DNA during follow-up.
   Radiother Oncol. 2023;190:110032.
   

   >> Share

   
   
7. BERBEE M, Muijs CT, Voncken FEM, Wee LS, et al
   External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts.
   Radiother Oncol. 2023 Nov 8:109979. doi: 10.1016/j.radonc.2023.109979.
   

   >> Share

   
   
8. HR M, P P, L H, Ds M, et al
   PROton versus photon Therapy for Esophageal Cancer - a Trimodality strategy (PROTECT) NCT050555648.
   Radiother Oncol. 2023 Nov 5:109980. doi: 10.1016/j.radonc.2023.109980.
   

   >> Share

   
   
9. CHEN L, Li J, Li K, Hu J, et al
   Evaluation and Analysis of Risk Factors of Hearing Impairment for Nasopharyngeal Carcinoma treated using Intensity-Modulated Radiotherapy.
   Radiother Oncol. 2023 Nov 3:109985. doi: 10.1016/j.radonc.2023.109985.
   

   >> Share

   
   
10. KIM K, Oh D, Myoung Noh J, Won Min Y, et al
    Outcomes Following Hypofractionated Radiation Therapy Alone for Surgically Unfit Early Esophageal Squamous Cell Carcinoma Patients; A Retrospective Single Center Analysis.
    Radiother Oncol. 2023 Nov 3:109982. doi: 10.1016/j.radonc.2023.109982.
    

    >> Share

    
    October 2023
11. HE YQ, Wang TM, Yang DW, Xue WQ, et al
    A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma.
    Radiother Oncol. 2023 Oct 30:109974. doi: 10.1016/j.radonc.2023.109974.
    

    >> Share

    
    
12. AMSTUTZ F, Krcek R, Bachtiary B, Weber DC, et al
    Treatment planning comparison for head and neck cancer between photon, proton, and combined proton-photon therapy - from a fixed beam line to an arc.
    Radiother Oncol. 2023 Oct 30:109973. doi: 10.1016/j.radonc.2023.109973.
    

    >> Share

    
    
13. FRIBORG J, Jensen K, Eriksen JG, Samsoe E, et al
    Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer.
    Radiother Oncol. 2023 Oct 21:109958. doi: 10.1016/j.radonc.2023.109958.
    

    >> Share

    
    
14. CHEN AM
    Management of Unknown Primary Head and Neck Cancer with Radiation Therapy in the Era of Human Papillomavirus (HPV): No Longer Cutting Down the Tree to Get an Apple.
    Radiother Oncol. 2023 Oct 14:109952. doi: 10.1016/j.radonc.2023.109952.
    

    >> Share

    
    
15. GAI X, Su L, Huang S, Zeng J, et al
    Correlation between hippocampal radiation doses and psychological condition for patients with stage T1-2 nasopharyngeal carcinoma.
    Radiother Oncol. 2023 Oct 7:109942. doi: 10.1016/j.radonc.2023.109942.
    

    >> Share

    
    
16. LI S, Zhang W, Liang B, Huang W, et al
    A Rulefit-Based Prognostic Analysis Using Structured MRI Report to Select Potential Beneficiaries from Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: A Dual-Centre Study.
    Radiother Oncol. 2023 Oct 7:109943. doi: 10.1016/j.radonc.2023.109943.
    

    >> Share

    
    
17. LIN CH, Yan JL, Yap WK, Kang CJ, et al
    Prognostic Value of Interim CT-based Peritumoral and Intratumoral Radiomics in Laryngeal and Hypopharyngeal Cancer Patients Undergoing Definitive Radiotherapy.
    Radiother Oncol. 2023 Oct 6:109938. doi: 10.1016/j.radonc.2023.109938.
    

    >> Share

    
    
18. SUN XS, Wang JW, Han F, Zou RH, et al
    Prognostic value of metastatic cervical lymph node stiffness in nasopharyngeal carcinoma: A prospective cohort study.
    Radiother Oncol. 2023 Oct 6:109939. doi: 10.1016/j.radonc.2023.109939.
    

    >> Share

    
    September 2023
19. YEONG SONG J, Sung Ho M, Suh YG, Kim JH, et al
    Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: a multicenter retrospective study (KROG 21-10).
    Radiother Oncol. 2023 Sep 30:109936. doi: 10.1016/j.radonc.2023.109936.
    

    >> Share

    
    
20. BOLLEN H, Gulyban A, Nuyts S
    Impact of consensus guidelines on delineation of primary tumor Clinical Target Volume (CTVp) for head and neck cancer: results of a national review project.
    Radiother Oncol. 2023 Sep 20:109915. doi: 10.1016/j.radonc.2023.109915.
    

    >> Share

    
    
21. LIU S, Zou Y, Zhong M, Li T, et al
    Prognostic Significance of MRI-Defined Sarcopenia in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matched Analysis of Real-World Data.
    Radiother Oncol. 2023 Sep 5:109904. doi: 10.1016/j.radonc.2023.109904.
    

    >> Share

    
    
22. YAN W, Liu T, He M, Yi J, et al
    Induction chemotherapy plus re-irradiation versus re-irradiation alone in locally recurrent nasopharyngeal carcinoma: A model-based analysis.
    Radiother Oncol. 2023 Sep 5:109903. doi: 10.1016/j.radonc.2023.109903.
    

    >> Share

    
    
23. ADRIAN G, Forslund O, Pedersen L, Sjovall J, et al
    Circulating tumour HPV16 DNA quantification - A prognostic tool for progression-free survival in patients with HPV-related oropharyngeal carcinoma receiving curative chemoradiotherapy.
    Radiother Oncol. 2023;186:109773.
    

    >> Share

    
    
24. SIJTSEMA ND, Verduijn GM, Nasserinejad K, van Norden Y, et al
    Development of a local dose-response relationship for osteoradionecrosis within the mandible.
    Radiother Oncol. 2023;186:109736.
    

    >> Share

    
    
25. LI D, Yang LN, Lin JY, Wu YZ, et al
    Eosinophil Dynamics During Chemo-Radiotherapy Correlate to Clinical Outcome in Stage ?-?a Nasopharyngeal Carcinoma Patients: Results from A Large Cohort Study.
    Radiother Oncol. 2023 Sep 1:109900. doi: 10.1016/j.radonc.2023.109900.
    

    >> Share

    
    August 2023
26. OZER O, Shafi H, O'Reilly D, Loiseau C, et al
    Need for standardization in the use of structures in the intensity-modulated radiation therapy planning of head and neck cancers, a GORTEC study.
    Radiother Oncol. 2023 Aug 31:109895. doi: 10.1016/j.radonc.2023.109895.
    

    >> Share

    
    
27. DING X, Cui X, Cui X, Wang S, et al
    Efficacy and toxicities of elective upper-neck irradiation versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: a meta-analysis.
    Radiother Oncol. 2023 Aug 23:109860. doi: 10.1016/j.radonc.2023.109860.
    

    >> Share

    
    
28. ROESCH J, Ruhle A, Nicolay NH, Hecht M, et al
    Reply to the comment on "Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis'' by Kahvecioglu et al.
    Radiother Oncol. 2023 Aug 22:109866. doi: 10.1016/j.radonc.2023.109866.
    

    >> Share

    
    
29. IYIZOBA-EBOZUE Z, Prestwich R, Brown S, Hall E, et al
    Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: a systematic review.
    Radiother Oncol. 2023 Aug 22:109863. doi: 10.1016/j.radonc.2023.109863.
    

    >> Share

    
    
30. KATSUTA T, Murakami Y, Kawahara D, Miyoshi S, et al
    Novel Simulation for Dosimetry Impact of Diaphragm Respiratory Motion in Four-Dimensional Volumetric Modulated Arc Therapy for Esophageal Cancer.
    Radiother Oncol. 2023 Aug 8:109849. doi: 10.1016/j.radonc.2023.109849.
    

    >> Share

    
    
31. BUURMAN DJM, Speksnijder CM, Granzier ME, C M L Timmer V, et al
    The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer.
    Radiother Oncol. 2023 Aug 3:109847. doi: 10.1016/j.radonc.2023.109847.
    

    >> Share

    
    
32. KOTEVSKI DP, Vajdic CM, Field M, Smee RI, et al
    Inter-hospital variation in data collection, radiotherapy treatment, and survival in patients with head and neck cancer: a multisite study.
    Radiother Oncol. 2023 Aug 3:109843. doi: 10.1016/j.radonc.2023.109843.
    

    >> Share

    
    
33. DIAS GOMES DA SILVA N, Sergio da Silva Santos P, Carolina Magalhaes A, Afonso Rabelo Buzalaf M, et al
    Antibacterial, antibiofilm and anticaries effect of BioXtra(R) mouthrinse for head and neck cancer (HNC) patients under a microcosm biofilm model.
    Radiother Oncol. 2023 Aug 3:109846. doi: 10.1016/j.radonc.2023.109846.
    

    >> Share

    
    July 2023
34. LIU J, Zhang B, Su Y, Qin G, et al
    Hypofractionated Radiotherapy compared with Conventionally Fractionated Radiotherapy to treat Initial Distant Metastases in Nasopharyngeal Carcinoma: A Multicenter, prospective, randomized, Phase II Trial.
    Radiother Oncol. 2023 Jul 20:109815. doi: 10.1016/j.radonc.2023.109815.
    

    >> Share

    
    
35. HANSEN CR, Jensen K, Smulders B, Holm AIS, et al
    Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35.
    Radiother Oncol. 2023 Jul 19:109812. doi: 10.1016/j.radonc.2023.109812.
    

    >> Share

    
    
36. KAHVECIOGLU A, Yuce Sari S, Yazici G
    Comments on ''Dose-escalated Re-irradiation Improves Outcome in Locally Recurrent Head and Neck Cancer - Results of a Large Multicenter Analysis''.
    Radiother Oncol. 2023 Jul 17:109809. doi: 10.1016/j.radonc.2023.109809.
    

    >> Share

    
    
37. LIN C, Lu N, Liang JL, Guo J, et al
    Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
    Radiother Oncol. 2023 Jul 7:109802. doi: 10.1016/j.radonc.2023.109802.
    

    >> Share

    
    
38. CONTI A
    In regard to: "Dosimetric predictive factors for facial nerve paralysis after Cyberknife stereotactic radiotherapy for vestibular schwannomas: A single institution experience of 88 patients".
    Radiother Oncol. 2023 Jul 6:109796. doi: 10.1016/j.radonc.2023.109796.
    

    >> Share

    
    
39. GEHIN W, Lassalle B, Salleron J, Anxionnat R, et al
    Response to the letter-to-the-editor "In regard to: Dosimetric predictive factors for facial nerve paralysis after Cyberknife stereotactic radiotherapy for vestibular schwannomas: A single institution experience of 88 patients".
    Radiother Oncol. 2023 Jul 6:109797. doi: 10.1016/j.radonc.2023.109797.
    

    >> Share

    
    
40. WEISS Y, Chin L, Younas E, Guo K, et al
    Cine MRI-based Analysis of Intrafractional Motion in Radiation Treatment Planning of Head and Neck Cancer Patients.
    Radiother Oncol. 2023 Jul 4:109790. doi: 10.1016/j.radonc.2023.109790.
    

    >> Share

    
    
41. LIN P, Holloway L, Min M, Lee M, et al
    Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles.
    Radiother Oncol. 2023;184:109686.
    

    >> Share

    
    
42. DE JONG BA, Korevaar EW, Maring A, Werkman CI, et al
    Proton arc therapy increases the benefit of proton therapy for oropharyngeal cancer patients in the model based clinic.
    Radiother Oncol. 2023;184:109670.
    

    >> Share

    
    
43. ZHOU J, Wu J, Wu G, Huang J, et al
    TBX18 knockdown sensitizes esophageal squamous cell carcinoma to radiotherapy by blocking the CHN1/RhoA axis.
    Radiother Oncol. 2023 Jul 1:109788. doi: 10.1016/j.radonc.2023.109788.
    

    >> Share

    
    June 2023
44. KJEMS J, Elisabet Hakansson K, Andrup Kristensen C, Grau Eriksen J, et al
    The influence of tumor volume on the risk of distant metastases in head and neck squamous cell carcinomas.
    Radiother Oncol. 2023 Jun 27:109771. doi: 10.1016/j.radonc.2023.109771.
    

    >> Share

    
    
45. LIN X, Guo Z, Lin S, Qiu Y, et al
    Transcriptional expression of radiation-induced early cortical morphological alterations and its association with radiation necrosis in patients with nasopharyngeal carcinoma.
    Radiother Oncol. 2023 Jun 27:109770. doi: 10.1016/j.radonc.2023.109770.
    

    >> Share

    
    
46. GAN Y, Langendijk JA, van der Schaaf A, van den Bosch L, et al
    An efficient strategy to select head and neck cancer patients for adaptive radiotherapy.
    Radiother Oncol. 2023 Jun 21:109763. doi: 10.1016/j.radonc.2023.109763.
    

    >> Share

    
    
47. YANG Q, Xia L, Feng LF, Gong WJ, et al
    Multi-trajectories of health-related quality of life and their associated factors in patients with nasopharyngeal carcinoma: A longitudinal study.
    Radiother Oncol. 2023 Jun 12:109743. doi: 10.1016/j.radonc.2023.109743.
    

    >> Share

    
    
48. ROJO-SANTIAGO J, Korevaar E, Perko Z, Both S, et al
    PTV-based VMAT vs. robust IMPT for Head-and-Neck Cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
    Radiother Oncol. 2023 Jun 8:109729. doi: 10.1016/j.radonc.2023.109729.
    

    >> Share

    
    
49. CAMPO F, Iocca O, De Virgilio A, Mazzola F, et al
    Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
    Radiother Oncol. 2023;183:109547.
    

    >> Share

    
    May 2023
50. KONG FF, Pan GS, Du CR, Ni MS, et al
    Prognostic value of circulating Epstein-Barr virus DNA level post-induction chemotherapy for patients with nasopharyngeal carcinoma: a recursive partitioning risk stratification analysis.
    Radiother Oncol. 2023 May 25:109721. doi: 10.1016/j.radonc.2023.109721.
    

    >> Share

    
    
51. MCDONALD BA, Salzillo T, Mulder S, Ahmed S, et al
    Prospective Evaluation of In Vivo and Phantom Repeatability and Reproducibility of Diffusion-Weighted MRI Sequences on 1.5T MRI-Linear Accelerator (MR-Linac) and MR Simulator Devices for Head and Neck Cancers.
    Radiother Oncol. 2023 May 19:109717. doi: 10.1016/j.radonc.2023.109717.
    

    >> Share

    
    
52. LU T, Xu H, Huang W, Zong J, et al
    Constructing an Individualized Surveillance Framework for Nasopharyngeal Carcinoma Based on a Dynamic Risk-adapted Approach.
    Radiother Oncol. 2023 May 17:109716. doi: 10.1016/j.radonc.2023.109716.
    

    >> Share

    
    
53. MORAL NAKAMURA D, da Graca Pinto H, Baena Elchin C, Thomazotti Berard L, et al
    Efficacy of bethanechol chloride in the treatment of radiation-induced xerostomia in patients with head and neck cancer: a systematic review and meta-analysis.
    Radiother Oncol. 2023 May 17:109715. doi: 10.1016/j.radonc.2023.109715.
    

    >> Share

    
    
54. LU J, Qin Z, Li N, Ma J, et al
    High-dose versus standard-dose radiotherapy in concurrent chemoradiotherapy for inoperable esophageal cancer: a systematic review and meta-analysis.
    Radiother Oncol. 2023 May 9:109700. doi: 10.1016/j.radonc.2023.109700.
    

    >> Share

    
    
55. FENG ZONG J, Lin PJ, Tsou HH, Guo Q, et al
    Comparison the Acute Toxicity of Two Different Induction Chemotherapy Schedules with Cisplatin and Fluorouracil in Nasopharyngeal Carcinoma Patients.
    Radiother Oncol. 2023 May 9:109699. doi: 10.1016/j.radonc.2023.109699.
    

    >> Share

    
    April 2023
56. ZHAO DW, Teng F, Meng LL, Fan WJ, et al
    Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.
    Radiother Oncol. 2023 Apr 27:109683. doi: 10.1016/j.radonc.2023.109683.
    

    >> Share

    
    
57. PAN Z, Men K, Liang B, Song Z, et al
    A subregion-based prediction model for local-regional recurrence risk in head and neck squamous cell carcinoma.
    Radiother Oncol. 2023 Apr 27:109684. doi: 10.1016/j.radonc.2023.109684.
    

    >> Share

    
    
58. ZHAO W, Ke S, Cai X, Zuo Z, et al
    Radiotherapy plus camrelizumaband irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial.
    Radiother Oncol. 2023 Apr 25:109679. doi: 10.1016/j.radonc.2023.109679.
    

    >> Share

    
    
59. A C FIAGAN Y, Bossuyt E, Nevens D, Machiels M, et al
    The use of in-vivo dosimetry to identify head and neck cancer patients needing adaptive radiotherapy.
    Radiother Oncol. 2023 Apr 19:109676. doi: 10.1016/j.radonc.2023.109676.
    

    >> Share

    
    March 2023
60. BOLOGNA M, Corino V, Cavalieri S, Calareso G, et al
    Prognostic radiomic signature for head and neck cancer: development and validation on a multi-centric MRI dataset.
    Radiother Oncol. 2023 Mar 31:109638. doi: 10.1016/j.radonc.2023.109638.
    

    >> Share

    
    
61. MENECEUR S, Lock S, Gudziol V, Hering S, et al
    Corrigendum to "Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens" [Radiother. Oncol. 137 (2019) 24-31].
    Radiother Oncol. 2023;183:109619.
    

    >> Share

    
    
62. S R MOHAMED A, Abusaif A, He R, Wahid K, et al
    Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study.
    Radiother Oncol. 2023 Mar 27:109641. doi: 10.1016/j.radonc.2023.109641.
    

    >> Share

    
    
63. LU ZJ, Liu T, Lin JY, Pei ST, et al
    Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma.
    Radiother Oncol. 2023 Mar 22:109635. doi: 10.1016/j.radonc.2023.109635.
    

    >> Share

    
    
64. ALY F, Ronn Hansen C, Al Mouiee D, Sundaresan P, et al
    Outcome prediction models incorporating clinical variables for Head and Neck Squamous cell Carcinoma: a systematic review of methodological conduct and risk of bias.
    Radiother Oncol. 2023 Mar 17:109629. doi: 10.1016/j.radonc.2023.109629.
    

    >> Share

    
    
65. DUBEC MJ, Buckley DL, Berks M, Clough A, et al
    First-in-Human Technique Translation of Oxygen-Enhanced MRI to an MR Linac System in Patients with Head and Neck Cancer.
    Radiother Oncol. 2023 Mar 2:109592. doi: 10.1016/j.radonc.2023.109592.
    

    >> Share

    
    
66. WU Z, Qi B, Lin FF, Zhang L, et al
    Characteristics of local extension based on tumor distribution in nasopharyngeal carcinoma and proposed clinical target volume delineation.
    Radiother Oncol. 2023 Mar 2:109595. doi: 10.1016/j.radonc.2023.109595.
    

    >> Share

    
    
67. WANG JH, Salama V, McCoy L, Dede C, et al
    Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation.
    Radiother Oncol. 2023;180:109465.
    

    >> Share

    
    February 2023
68. TAN W, Mao M, He H, Chen M, et al
    Endonasopharyngeal Ultrasound and Magnetic Resonance Imaging Features of Recurrent Retropharyngeal Nodes in Nasopharyngeal Carcinoma Patients: A Radiologic-histopathologic Study.
    Radiother Oncol. 2023 Feb 24:109579. doi: 10.1016/j.radonc.2023.109579.
    

    >> Share

    
    
69. BOLLEN H, Willems S, Wegge M, Maes F, et al
    Benefits of automated gross tumor volume segmentation in head and neck cancer using multi-modality information.
    Radiother Oncol. 2023 Feb 21:109574. doi: 10.1016/j.radonc.2023.109574.
    

    >> Share

    
    
70. ZHANG J, Lam SK, Teng X, Ma Z, et al
    Radiomic Feature Repeatability and Its Impact on Prognostic Model Generalizability: A Multi-Institutional Study on Nasopharyngeal Carcinoma Patients.
    Radiother Oncol. 2023 Feb 21:109578. doi: 10.1016/j.radonc.2023.109578.
    

    >> Share

    
    
71. VALENTINI C, Ebert N, Koi L, Pfeifer M, et al
    Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour models.
    Radiother Oncol. 2023 Feb 20:109546. doi: 10.1016/j.radonc.2023.109546.
    

    >> Share

    
    
72. BEYAN C, Beyan E
    The prognosis may not be determined with the use of some pre-treatment complete blood count values in patients with non-metastatic nasopharyngeal carcinoma.
    Radiother Oncol. 2023 Feb 9:109529. doi: 10.1016/j.radonc.2023.109529.
    

    >> Share

    
    
73. MAO JR, Lan KQ, Liu SL, Liu C, et al
    In reply to the Letter to the Editor by Cengiz Beyan and Esin Beyan regarding ''Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?".
    Radiother Oncol. 2023 Feb 9:109530. doi: 10.1016/j.radonc.2023.109530.
    

    >> Share

    
    
74. PATRICIA KAPLAN L, Ivalu Sander Holm A, Grau Eriksen J, Heijmen BJM, et al
    Patient anatomy-specific trade-offs between sub-clinical disease coverage and normal tissue dose reduction in head-and-neck cancer.
    Radiother Oncol. 2023 Feb 8:109526. doi: 10.1016/j.radonc.2023.109526.
    

    >> Share

    
    
75. GEHIN W, Lassalle B, Salleron J, Anxionnat R, et al
    DOSIMETRIC PREDICTIVE FACTORS FOR FACIAL NERVE PARALYSIS AFTER CYBERKNIFE(R) STEREOTACTIC RADIOTHERAPY FOR VESTIBULAR SCHWANNOMAS: A SINGLE INSTITUTION EXPERIENCE OF 88 PATIENTS.
    Radiother Oncol. 2023 Feb 1:109519. doi: 10.1016/j.radonc.2023.109519.
    

    >> Share

    
    January 2023
76. YAO JJ, Jin YN, Zhang WJ, Zhang HY, et al
    Response to the letter by Dr Sari regarding the article "The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy".
    Radiother Oncol. 2023 Jan 31:109487. doi: 10.1016/j.radonc.2023.109487.
    

    >> Share

    
    
77. TERZIDIS E, Friborg J, Vogelius I, Lelkaitis G, et al
    Tumor volume definitions in head and neck squamous cell carcinoma - comparing PET/MRI and histopathology.
    Radiother Oncol. 2023 Jan 20:109484. doi: 10.1016/j.radonc.2023.109484.
    

    >> Share

    
    
78. YE X, Liu J, Quan R, Lu Y, et al
    DKK1 Affects Survival of Patients with Head and Neck Squamous Cell Carcinoma by Inducing Resistance to Radiotherapy and Immunotherapy.
    Radiother Oncol. 2023 Jan 20:109485. doi: 10.1016/j.radonc.2023.109485.
    

    >> Share

    
    
79. LUO X, Liao W, He Y, Tang F, et al
    Deep learning-based accurate delineation of primary gross tumor volume of nasopharyngeal carcinoma on heterogeneous magnetic resonance imaging: a large-scale and multi-center study.
    Radiother Oncol. 2023 Jan 16:109480. doi: 10.1016/j.radonc.2023.109480.
    

    >> Share

    
    
80. WANG X, Bai H, Li R, Wang L, et al
    High versus Standard Radiation Dose of Definitive Concurrent Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Radiother Oncol. 2023 Jan 12:109463. doi: 10.1016/j.radonc.2023.109463.
    

    >> Share

    
    
81. LI Y, Sijtsema NM, de Vette SPM, Steenbakkers RJHM, et al
    Validation of the (18)F-FDG PET image biomarker model predicting late xerostomia after head and neck cancer radiotherapy.
    Radiother Oncol. 2023 Jan 3:109458. doi: 10.1016/j.radonc.2022.109458.
    

    >> Share

    
    
82. GUEVORGUIAN P, Chinnery T, Lang P, Nichols A, et al
    External validation of a CT-based radiomics signature in oropharyngeal cancer: Assessing sources of variation.
    Radiother Oncol. 2023;178:109434.
    

    >> Share

    
    December 2022
83. LEEUWENBERG AM, Reitsma JB, Bosch LVD, Hoogland J, et al
    The relation between prediction model performance measures and patient selection outcomes for proton therapy in head and neck cancer.
    Radiother Oncol. 2022 Dec 22:109449. doi: 10.1016/j.radonc.2022.109449.
    

    >> Share

    
    
84. HUANG X, Zhuang M, Yang S, Wang Y, et al
    The valuable role of dynamic (18)F FDG PET/CT-derived kinetic parameter K(i) in patients with nasopharyngeal carcinoma prior to radiotherapy: a prospective study.
    Radiother Oncol. 2022 Dec 22:109440. doi: 10.1016/j.radonc.2022.109440.
    

    >> Share

    
    
85. MAO JR, Lan KQ, Liu SL, Liu C, et al
    Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?
    Radiother Oncol. 2022 Dec 22:109445. doi: 10.1016/j.radonc.2022.109445.
    

    >> Share

    
    
86. LIU Y, Zhang Y, Wang J, Huang X, et al
    Caudal distribution pattern of metastatic neck lymph nodes in nasopharyngeal carcinoma and prognostic significance of nodal spread distances.
    Radiother Oncol. 2022 Dec 19:109443. doi: 10.1016/j.radonc.2022.109443.
    

    >> Share

    
    
87. ZHU GL, Zhang XM, Yang KB, Tang LL, et al
    Metastatic patterns of level II-V cervical lymph nodes assessed per vertebral levels in nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Dec 19:109447. doi: 10.1016/j.radonc.2022.109447.
    

    >> Share

    
    
88. ZENG GP, Sun R, Zhao Z
    Letter to the editor regarding "The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction".
    Radiother Oncol. 2022 Dec 14:109442. doi: 10.1016/j.radonc.2022.109442.
    

    >> Share

    
    
89. HU YJ, Lu TZ, Guo QJ, Zhang L, et al
    The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2N1 nasopharyngeal carcinoma: a multicenter retrospective study.
    Radiother Oncol. 2022 Dec 1:S0167-8140(22)04582.
    

    >> Share

    
    
90. DE FELICE F, Cirillo A, Botticelli A
    Ideal regimen for induction chemotherapy in nasopharyngeal cancer: Still a hot issue?
    Radiother Oncol. 2022;177:111-112.
    

    >> Share

    
    November 2022
91. CHEN WY, Lu SH, Wang YM, Wang CW, et al
    Post-irradiation Sarcoma after Definitive Radiation Therapy for Nasopharyngeal Carcinoma.
    Radiother Oncol. 2022 Nov 23:S0167-8140(22)04560.
    

    >> Share

    
    
92. LIU ZC, Zeng KH, Gu ZB, Chen RP, et al
    Comparison of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in Lymph-Node-Stage Nasopharyngeal Carcinoma based on propensity score-matching.
    Radiother Oncol. 2022 Nov 18:S0167-8140(22)04554.
    

    >> Share

    
    
93. WANG G, Huang C, Yang K, Guo R, et al
    Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
    Radiother Oncol. 2022 Nov 11. pii: S0167-8140(22)04548.
    

    >> Share

    
    
94. YAO JJ, Jin YN, Lin YJ, Zhang WJ, et al
    The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy.
    Radiother Oncol. 2022 Nov 11. pii: S0167-8140(22)04547.
    

    >> Share

    
    
95. BIN Y, Meng Z, Huang LL, Hu XY, et al
    Prognostic value of the cervical lymph node necrosis ratio in nasopharyngeal carcinoma.
    Radiother Oncol. 2022 Nov 11. pii: S0167-8140(22)04549.
    

    >> Share

    
    
96. TAKADA A, Ichikawa Y, Nakamura S, Toyomasu Y, et al
    Preliminary results of reduced myocardial blood flow in the subacute phase after radiation therapy for thoracic esophageal cancer: A quantitative analysis with stress dynamic myocardial computed tomography perfusion imaging.
    Radiother Oncol. 2022 Nov 10. pii: S0167-8140(22)04546.
    

    >> Share

    
    
97. ZHONG Z, Wang D, Liu Y, Shao S, et al
    Lymph Drainage and Cervical Fascia Anatomy-Oriented Differential Nodal CTV Delineation at the Supraclavicular Region for Esophageal Cancer and Nasopharyngeal Cancer.
    Radiother Oncol. 2022 Nov 3. pii: S0167-8140(22)04531.
    

    >> Share

    
    
98. CHOW JCH, Lui JCF, Cheung KM, Tam AHP, et al
    Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
    Radiother Oncol. 2022 Nov 3. pii: S0167-8140(22)04529.
    

    >> Share

    
    
99. HUANG H, Miao J, Zhao C, Wang L, et al
    Response to Gargi S Sarode, Sachin C Sarode, and Rahul Anand's Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing inten
    Radiother Oncol. 2022 Nov 2. pii: S0167-8140(22)04517.
    

    >> Share

    
    
100. SARODE GS, Sarode SC, Anand R
     Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective pha
     Radiother Oncol. 2022 Nov 2. pii: S0167-8140(22)04515.
     

     >> Share

     
     
101. LEE CT, Litwin S, Yao CMKL, Liu JC, et al
     Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints.
     Radiother Oncol. 2022;176:215-221.
     

     >> Share

     
     
102. VAN DER WEIJST L, Azria D, Berkovic P, Boisselier P, et al
     The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.
     Radiother Oncol. 2022;176:127-137.
     

     >> Share

     
     October 2022
103. ROESCH J, Oertel M, Wegen S, Trommer M, et al
     Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis.
     Radiother Oncol. 2022 Oct 20. pii: S0167-8140(22)04502.
     

     >> Share

     
     
104. TIEN CT, Chen CN, Young YH
     Post-irradiation endolymphatic hydrops vs. post-irradiation sudden deafness.
     Radiother Oncol. 2022 Oct 17. pii: S0167-8140(22)04504.
     

     >> Share

     
     
105. RONN HANSEN C, Price G, Field M, Sarup N, et al
     Larynx cancer survival model developed through open-source federated learning.
     Radiother Oncol. 2022 Oct 5. pii: S0167-8140(22)04493.
     

     >> Share

     
     September 2022
106. NADERI E, Schack LMH, Welsh C, Sim AYL, et al
     Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer.
     Radiother Oncol. 2022 Sep 30. pii: S0167-8140(22)04486.
     

     >> Share

     
     
107. HUMBERT-VIDAN L, Hansen CR, Fuller CD, Petit S, et al
     Protocol Letter: A multi-institutional retrospective case-control cohort investigating PREDiction models for Mandibular OsteoRadioNecrosis in head and neck cancer (PREDMORN).
     Radiother Oncol. 2022 Sep 27. pii: S0167-8140(22)04473.
     

     >> Share

     
     
108. DRAGUET C, Barragan-Montero AM, Chocan Vera M, Thomas M, et al
     Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer.
     Radiother Oncol. 2022 Sep 24. pii: S0167-8140(22)04263.
     

     >> Share

     
     
109. OUD M, Breedveld S, Gizynska M, Kroesen M, et al
     An online adaptive plan library approach for intensity modulated proton therapy for head and neck cancer.
     Radiother Oncol. 2022 Sep 20. pii: S0167-8140(22)04278.
     

     >> Share

     
     August 2022
110. DE ROEST RH, van der Heijden M, W R Wesseling F, de Ruiter EJ, et al
     Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
     Radiother Oncol. 2022 Aug 13. pii: S0167-8140(22)04234.
     

     >> Share

     
     
111. ZHANG Y, Alshaikhi J, Amos RA, Lowe M, et al
     Improving workflow for adaptive proton therapy with predictive anatomical modelling: A proof of concept.
     Radiother Oncol. 2022;173:93-101.
     

     >> Share

     
     July 2022
112. GHATASHEH H, Hui Huang S, Su J, Xu W, et al
     Evaluation of risk-tailored individualized selection of radiation therapy target volume for Head and Neck Carcinoma of Unknown Primary.
     Radiother Oncol. 2022 Jul 26. pii: S0167-8140(22)04214.
     

     >> Share

     
     
113. HABRICH J, Boeke S, Nachbar M, Nikolaou K, et al
     Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac.
     Radiother Oncol. 2022 Jul 25. pii: S0167-8140(22)04218.
     

     >> Share

     
     
114. HUANG H, Miao J, Xiao X, Hu J, et al
     Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): a prospective phase II randomized controlled study.
     Radiother Oncol. 2022 Jul 8. pii: S0167-8140(22)04191.
     

     >> Share

     
     
115. PRICE JM, West CM, Dixon LM, Iyizoba-Ebozue Z, et al
     Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
     Radiother Oncol. 2022;172:111-117.
     

     >> Share

     
     June 2022
116. QIAN D, Chen X, Shang X, Wang Y, et al
     Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II rando
     Radiother Oncol. 2022 Jun 25. pii: S0167-8140(22)04176.
     

     >> Share

     
     
117. KROESE TE, Christ SM, van Rossum PSN, Burger MDL, et al
     Incidence and survival of patients with oligometastatic esophagogastric cancer: a multicenter cohort study.
     Radiother Oncol. 2022 Jun 23. pii: S0167-8140(22)04173.
     

     >> Share

     
     
118. GONG J, Zhang W, Huang W, Liao Y, et al
     CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study.
     Radiother Oncol. 2022 Jun 21. pii: S0167-8140(22)04171.
     

     >> Share

     
     
119. HANSEN CR, Price G, Field M, Sarup N, et al
     Open-source distributed learning validation for a larynx cancer survival model following radiotherapy.
     Radiother Oncol. 2022 Jun 20. pii: S0167-8140(22)04170.
     

     >> Share

     
     
120. FU G, Xie Y, Pan J, Qiu Y, et al
     Longitudinal study of irradiation-induced brain functional network alterations in patients with nasopharyngeal carcinoma.
     Radiother Oncol. 2022 Jun 16. pii: S0167-8140(22)04164.
     

     >> Share

     
     
121. SCHOONBEEK RC, Festen S, van der Laan BFAM, Plaat BEC, et al
     The effect of delayed treatment initiation on adverse events and recurrence in older head and neck cancer patients.
     Radiother Oncol. 2022 Jun 6. pii: S0167-8140(22)04146.
     

     >> Share

     
     
122. MASSACCESI M, Dinapoli N, Fuga V, Rupe C, et al
     A predictive nomogram for trismus after radiotherapy for head and neck cancer.
     Radiother Oncol. 2022 Jun 2. pii: S0167-8140(22)04137.
     

     >> Share

     
     May 2022
123. LIU Z, Luo Y, Guo R, Yang B, et al
     Head and Neck Radiotherapy Causes Significant Disruptions of Cochlear Ribbon Synapses and Consequent Sensorineural Hearing Loss.
     Radiother Oncol. 2022 May 28. pii: S0167-8140(22)02279.
     

     >> Share

     
     
124. ZHAO DW, Fan WJ, Fang XM, Luo YR, et al
     Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
     Radiother Oncol. 2022 May 15. pii: S0167-8140(22)00251.
     

     >> Share

     
     
125. YI-LIANG SHEN E, Hung TM, Tsan DL, Cheng NM, et al
     Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating epstein-barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma.
     Radiother Oncol. 2022 May 11. pii: S0167-8140(22)00240.
     

     >> Share

     
     April 2022
126. ZHAO Y, Liao X, Wang Y, Lan W, et al
     Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy.
     Radiother Oncol. 2022 Apr 29. pii: S0167-8140(22)00232.
     

     >> Share

     
     
127. DOHOPOLSKI M, Wang K, Morgan H, Sher D, et al
     Predicting the need for aggressive nutritional supplementation in head and neck cancer patients receiving radiation therapy.
     Radiother Oncol. 2022 Apr 21. pii: S0167-8140(22)00224.
     

     >> Share

     
     
128. SHEN H, Yin J, Niu R, Lian Y, et al
     Development and validation of a radiomic nomogram to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carc
     Radiother Oncol. 2022 Apr 21. pii: S0167-8140(22)00222.
     

     >> Share

     
     
129. LEE BM, Lee CG
     Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer.
     Radiother Oncol. 2022 Apr 18. pii: S0167-8140(22)00191.
     

     >> Share

     
     
130. WELZ S, Paulsen F, Pfannenberg C, Reimold M, et al
     Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [(18)F]FMISO PET/CT.
     Radiother Oncol. 2022 Apr 5. pii: S0167-8140(22)00170.
     

     >> Share

     
     
131. JENSEN KH, Vogelius IR, Bernsdorf M, Gothelf A, et al
     Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma.
     Radiother Oncol. 2022 Apr 5. pii: S0167-8140(22)00169.
     

     >> Share

     
     
132. LUDWIG R, Hoffmann JM, Pouymayou B, Dappen MB, et al
     Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface.
     Radiother Oncol. 2022;169:1-7.
     

     >> Share

     
     March 2022
133. YUE M, Xue X, Wang Z, Lambo RL, et al
     Dose prediction via distance-guided deep learning: initial development for nasopharyngeal carcinoma radiotherapy.
     Radiother Oncol. 2022 Mar 26. pii: S0167-8140(22)00150.
     

     >> Share

     
     
134. BORDERIAS-VILLARROEL E, Taasti V, Van Elmpt W, Teruel-Rivas S, et al
     Evaluation of the clinical value of automatic online dose restoration for adaptive proton therapy of head and neck cancer.
     Radiother Oncol. 2022 Mar 25. pii: S0167-8140(22)00149.
     

     >> Share

     
     
135. KARAVOLIA E, van Rijn-Dekker MI, Van den Bosch L, van den Hoek JGM, et al
     Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients.
     Radiother Oncol. 2022 Mar 15. pii: S0167-8140(22)00145.
     

     >> Share

     
     
136. ZHOU X, Wang W, Zhou C, Zhu J, et al
     Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
     Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00132.
     

     >> Share

     
     
137. HUANG CC, Lai YR, Chiu WC, Fang FM, et al
     Concurrent chemoradiation therapy is associated with an accelerated risk of cardiovascular autonomic dysfunction in patients with nasopharyngeal carcinoma: A 9-year prospective follow-up study.
     Radiother Oncol. 2022 Mar 11. pii: S0167-8140(22)00129.
     

     >> Share

     
     
138. CHOW R, Simone CB 2nd
     Radiation induced lymphopenia in head and neck cancer: The importance of rigorous statistical analysis, radiation field size, and treatment modality.
     Radiother Oncol. 2022 Mar 10. pii: S0167-8140(22)00112.
     

     >> Share

     
     
139. DAI D, Tian Q, Shui Y, Li J, et al
     Response to "Radiation induced lymphopenia in head and neck cancer: The importance of rigorous statistical analysis, radiation field size, and treatment modality".
     Radiother Oncol. 2022 Mar 10. pii: S0167-8140(22)00109.
     

     >> Share

     
     
140. NACHANKAR A, Musha A, Kubo N, Kawamura H, et al
     Dosimetric analysis of intraocular hemorrhage in nonsquamous head and neck cancers treated with carbon-ion radiotherapy.
     Radiother Oncol. 2022 Mar 4. pii: S0167-8140(22)00118.
     

     >> Share

     
     
141. GORPHE P, Classe M, Ammari S, Garcia G, et al
     Patterns of disease events and causes of death in patients with HPV-positive versus HPV-negative oropharyngeal carcinoma.
     Radiother Oncol. 2022;168:40-45.
     

     >> Share

     
     February 2022
142. LASKAR SG, Sinha S, Pai DP, Nair D, et al
     Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomes.
     Radiother Oncol. 2022 Feb 24. pii: S0167-8140(22)00106.
     

     >> Share

     
     
143. BONOMO P, Desideri I, Mangoni M, Saieva C, et al
     Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: a phase 1/2 trial.
     Radiother Oncol. 2022 Feb 11. pii: S0167-8140(22)00091.
     

     >> Share

     
     
144. SCANDURRA D, Meijer TWH, Free J, van den Hoek JGM, et al
     Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma.
     Radiother Oncol. 2022 Feb 5. pii: S0167-8140(22)00080.
     

     >> Share

     
     
145. PAN D, Rong X, Zhu Y, Ng WT, et al
     A novel nomogram to predict overall survival in head and neck cancer survivors with radiation-induced brain necrosis.
     Radiother Oncol. 2022 Feb 1. pii: S0167-8140(22)00060.
     

     >> Share

     
     January 2022
146. SUN XS, Zhu MY, Wen DX, Luo DH, et al
     Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in local recurrence nasopharyngeal carcinoma patients.
     Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00028.
     

     >> Share

     
     
147. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
     Head and neck cancer diagnoses and faster treatment initiation during COVID-19: correspondence.
     Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00026.
     

     >> Share

     
     
148. SCHOONBEEK RC, de Jel DVC, van Dijk BAC, Willems SM, et al
     Response to "Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence".
     Radiother Oncol. 2022 Jan 28. pii: S0167-8140(22)00033.
     

     >> Share

     
     
149. CHATTERJEE S, Maulik S, Prasath S, Arun B, et al
     Xerostomia quality of life and resource requirements following parotid sparing adaptive radiotherapy in head and neck cancers: Results of a prospective cohort study (Study ID CTRI/2017/11/010683).
     Radiother Oncol. 2022 Jan 27. pii: S0167-8140(22)00024.
     

     >> Share

     
     
150. ZECH HB, Berger J, Mansour WY, Nordquist L, et al
     Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer.
     Radiother Oncol. 2022 Jan 27. pii: S0167-8140(22)00022.
     

     >> Share

     
     
151. AL-MAMGANI A, Kessels R, Janssen T, Navran A, et al
     The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6mm in head and neck squamous cell carcinoma: significant acute and late toxicity reduction.
     Radiother Oncol. 2022 Jan 20. pii: S0167-8140(22)00017.
     

     >> Share

     
     
152. HE J, Qian L, Gao J
     Comment on ''Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)".
     Radiother Oncol. 2022 Jan 19. pii: S0167-8140(22)00005.
     

     >> Share

     
     
153. ROBIJNS J, Lodewijckx J, Claes S, Van Bever L, et al
     Response to the Comment on ''Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)"by He et al.
     Radiother Oncol. 2022 Jan 19. pii: S0167-8140(22)00006.
     

     >> Share

     
     
154. DAI D, Tian Q, Shui Y, Li J, et al
     The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis.
     Radiother Oncol. 2022 Jan 8. pii: S0167-8140(22)00007.
     

     >> Share

     
     
155. HUANG W, Zhang Q, Wu G, Chen P, et al
     Corrigendum to "DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients" [Radiother Oncol (2021) 164:146-154].
     Radiother Oncol. 2022 Jan 7. pii: S0167-8140(21)09059.
     

     >> Share

     
     
156. LIU T, Shen BW, Liu LT, Yang ZC, et al
     Impact of salvage radiotherapy on survival of patients with advanced locally recurrent nasopharyngeal carcinoma: Derivation and validation of a predictive model.
     Radiother Oncol. 2022 Jan 5. pii: S0167-8140(21)09094.
     

     >> Share

     
     
157. FORNER LE, Dieleman FJ, Shaw RJ, Kanatas A, et al
     Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1.
     Radiother Oncol. 2022;166:137-144.
     

     >> Share

     
     December 2021
158. GUO Q, Xiao N, Xu H, Zong J, et al
     Rationality of the international guideline's recommendation regarding selective coverage of level Ib in clinical target volume with nasopharyngeal carcinoma: Results from a real-world series.
     Radiother Oncol. 2021 Dec 29. pii: S0167-8140(21)09081.
     

     >> Share

     
     
159. TANG SQ, Chen L, Li WF, Chan ATC, et al
     Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9,468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial.
     Radiother Oncol. 2021 Dec 28. pii: S0167-8140(21)09077.
     

     >> Share

     
     
160. SCHOONBEEK RC, de Jel DVC, van Dijk BAC, Willems SM, et al
     Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: a nationwide population-based analysis.
     Radiother Oncol. 2021 Dec 13. pii: S0167-8140(21)09049.
     

     >> Share

     
     
161. MUSHA A, Hirai C, Kitada Y, Tsunoda A, et al
     Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study.
     Radiother Oncol. 2021 Dec 10. pii: S0167-8140(21)09054.
     

     >> Share

     
     
162. BEUKEMA JC, de Groot C, Plukker JTM, Vliegenthart R, et al
     Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: a prospective cross-sectional pilot study.
     Radiother Oncol. 2021 Dec 2. pii: S0167-8140(21)09025.
     

     >> Share

     
     November 2021
163. KUTZ LM, Abel J, Schweizer D, Tribius S, et al
     Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial.
     Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09004.
     

     >> Share

     
     
164. JIN YN, Yang QQ, Li ZQ, Ou XQ, et al
     Development of a Web-based Prognostic Model to Quantify the Survival Benefit of Cumulative Cisplatin Dose during Concurrent Chemoradiotherapy in Childhood Nasopharyngeal Carcinoma.
     Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09008.
     

     >> Share

     
     
165. NISHIBUCHI I, Murakami Y, Kubo K, Imano N, et al
     Temporal Changes and Risk Factors for Esophageal Stenosis after Salvage Radiotherapy in Superficial Esophageal Cancer following Non-Curative Endoscopic Submucosal Dissection.
     Radiother Oncol. 2021 Nov 25. pii: S0167-8140(21)09007.
     

     >> Share

     
     
166. PATEL V, Kwok J, Burke M, Urbano TG, et al
     Should the HPV positive oropharyngeal cancer patient be considered for a two-stage dental assessment for their radiation treatment?
     Radiother Oncol. 2021;164:232-235.
     

     >> Share

     
     
167. GAWRYSZUK A, Bijl HP, van der Schaaf A, Perdok N, et al
     Relationship between videofluoroscopic and subjective (physician- and patient- rated) assessment of late swallowing dysfunction after (chemo) radiation: Results of a prospective observational study.
     Radiother Oncol. 2021;164:253-260.
     

     >> Share

     
     October 2021
168. BROOKER RC, Antczak P, Liloglou T, Risk JM, et al
     Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy.
     Radiother Oncol. 2021;165:87-93.
     

     >> Share

     
     
169. CHIN O, Yu E, O'Sullivan B, Su J, et al
     Prognostic Importance of Radiologic Extranodal Extension in Nasopharyngeal Carcinoma Treated in a Canadian Cohort.
     Radiother Oncol. 2021 Oct 27. pii: S0167-8140(21)08785.
     

     >> Share

     
     
170. ZHANG ZM, Zhao R, Bao Y, Zhou LX, et al
     A novel technique of endonasopharyngeal ultrasound-guided transnasopharyngeal needle aspiration in the diagnosis of submucosal recurrence of nasopharyngeal carcinoma after chemoradiotherapy.
     Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08758.
     

     >> Share

     
     
171. SHI Z, Zhu X, Ke S, Qiu H, et al
     Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: a propensity score matching and landmark analyses.
     Radiother Oncol. 2021 Oct 7. pii: S0167-8140(21)08754.
     

     >> Share

     
     
172. YAN A, Hanna A, Wilson TG, Deraniyagala R, et al
     Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
     Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)08748.
     

     >> Share

     
     
173. KANEHIRA T, van Kranen S, Jansen T, Hamming-Vrieze O, et al
     Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
     Radiother Oncol. 2021 Oct 4. pii: S0167-8140(21)06738.
     

     >> Share

     
     September 2021
174. HUANG W, Zhang Q, Wu G, Pian Chen P, et al
     DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
     Radiother Oncol. 2021 Sep 27. pii: S0167-8140(21)06739.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share